医学
心脏毒性
癌症
心房颤动
心力衰竭
重症监护医学
心肌炎
生活质量(医疗保健)
癌症治疗
内科学
心脏病学
化疗
护理部
作者
Naga Venkata K. Pothineni,Herman van Besien,Michael G. Fradley
标识
DOI:10.1016/j.hfc.2022.02.006
摘要
Over the last several decades, advancements in cancer screening and treatment have significantly improved cancer mortality and overall quality of life. Unfortunately, non-cancer-related side effects, including cardiovascular toxicities can impact the continued delivery of these treatments. Arrhythmias are an increasingly recognized class of cardiotoxicity that can occur as a direct consequence of the treatment or secondary to another type of toxicity such as heart failure, myocarditis, or ischemia. Atrial arrhythmias, particularly atrial fibrillation (AF) are most commonly encountered, however, ventricular- and bradyarrhythmias can also occur, albeit at lower rates. Treatment strategies tailored to patients with cancer are essential to allow for the safe delivery of the cancer treatment without affecting short- or long-term oncologic or cardiovascular outcomes.
科研通智能强力驱动
Strongly Powered by AbleSci AI